ANI PHARMACEUTICALS INC — Director's Dealing 2013

Jul 16, 2013

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: BIOSANTE PHARMACEUTICALS INC (BPAX)
CIK: 0001023024
Period of Report: 2013-07-12

Reporting Person: RAYNOR DANIEL (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	3345849	Indirect

Footnotes

F1: These shares are held by Argentum Capital Partners II, L.P. (ACP II). Argentum Investments, LLC is the managing member of Argentum Partners II, LLC, which is the general partner of ACP II. Daniel Raynor is a co-managing member of Argentum Investments, LLC. Mr. Raynor disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein. The business address of ACP II is 60 Madison Avenue, Suite 701, New York, NY 10010.